PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35462489-1	2022	Objective: To dynamically observe the clinical efficacy of entecavir and the changes of PD-1+CXCR5+CD4+T lymphocytes and sPD-1 levels in peripheral blood of HBeAg-positive chronic hepatitis B virus carriers treated with entecavir, and further explore its clinical significance.	entecavir	220-229	programmed cell death 1	Homo sapiens	88-92	
35462489-0	2022	(Observation of PD-1+CXCR5+CD4+T lymphocyte and sPD-1 levels in HBeAg positive chronic hepatitis B virus carriers treated with entecavir).	entecavir	127-136	programmed cell death 1	Homo sapiens	16-20	
34016716-6	2021	Soluble programmed cell death protein 1 and sTIM-3 both positively correlated with hepatitis B virus (HBV) DNA level and increased in entecavir or tenofovir used group.	entecavir	134-143	programmed cell death 1	Homo sapiens	8-39	
21492509-0	2011	[Relationship between PD-1 expression on peripheral T lymphcytes and HBeAg seroconversion after entecavir treatment in chronic hepatitis B patients].	entecavir	96-105	programmed cell death 1	Homo sapiens	22-26